Top Markets
Coin of the day
Bright Minds Biosciences Inc. Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

DRUG
Rankning i aktier #11319
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics... Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Aktiekurs
$73.12
Senast synkroniserad: 2026-08-28
Marknadsvärde
$715.61M
Förändring (1 dag)
-1.90%
Förändring (1 år)
88.01%
Land
US
Handel Bright Minds Biosciences Inc. (DRUG)

Kategori

Historik för aktiesplit för Bright Minds Biosciences Inc. (DRUG)
Aktien Bright Minds Biosciences Inc. (symbol: DRUG) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 30, 2026.
En DRUG-aktie köpt före Aug 30, 2026 motsvarar nu 0 DRUG-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH